SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms

Overview of attention for article published in Annals of Allergy, Asthma & Immunology, February 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 7 X users

facebook: 4 Facebook pages

Citations

dimensions_citation: 78 Dimensions

Readers on

mendeley: 93 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 78 publications that cite this research output.

78

The most recent citing publications are shown below. View all 78 publications that cite this research output on Dimensions.

House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice

Article in Frontiers in Allergy (February 2024)

Approaches to Management of Asthma: Guidelines for Stepped Care and Self-Monitoring

Book chapter (July 2023)

Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper

Article in Allergy (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.